Canada Semaglutide Go-ahead: Which Way Will The Wind Blow For Dr Reddy’s?

 
• By Anju Ghangurde
  
Maple leaves
Dr Reddy's awaits feedback from the Canadian regulator for semaglutide (Shutterstock)

More from Focus On Asia

More from Scrip